Bioengineered bacterial outer membrane vesicles as cell-specific drug-delivery vehicles for cancer therapy

ACS Nano

Volumn 8, Issue 2, 2014, Pages 1525-1537

  Gujrati, Vipul ^a   Kim, Sunghyun ^a   Kim, Sang Hyun ^b   Min, Jung Joon ^c   Choy, Hyon E ^c   Kim, Sun Chang ^a   Jon, Sangyong ^a  

^a Korea Advanced Institute of Science and Technology (KAIST)   (South Korea)

^b Korea Research Institute of Bioscience and Biotechnology (KRIBB)   (South Korea)

^c Chonnam National University Hwasun Hospital and Medical School   (South Korea)

Author keywords

affibody; cancer therapy; drug delivery; outer membrane vesicles; siRNA

Indexed keywords

ANTINEOPLASTIC AGENT; DRUG CARRIER; OUTER MEMBRANE PROTEIN;

ARTICLE; GENETICS; NEOPLASM;

ANTINEOPLASTIC AGENTS; BACTERIAL OUTER MEMBRANE PROTEINS; DRUG CARRIERS; NEOPLASMS;

EID: 84894630001     PISSN: 19360851     EISSN: 1936086X     Source Type: Journal    
DOI: 10.1021/nn405724x     Document Type: Article

References (49)

1. Petros, R. A.; DeSimone, J. M. Strategies in the Design of Nanoparticles for Therapeutic Applications Nat. Rev. Drug Discovery 2010, 9, 615-627
2. Soussan, E.; Cassel, S.; Blanzat, M.; Rico-Lattes, I. Drug Delivery by Soft Matter: Matrix and Vesicular Carriers Angew. Chem., Int. Ed. 2009, 48, 274-288
3. Farokhzad, O. C.; Langer, R. Impact of Nanotechnology on Drug Delivery ACS Nano 2009, 3, 16-20
4. Shi, J. J.; Votruba, A. R.; Farokhzad, O. C.; Langer, R. Nanotechnology in Drug Delivery and Tissue Engineering: From Discovery to Applications Nano Lett. 2010, 10, 3223-3230
5. Adair, J. H.; Parette, M. P.; Altinoglu, E. I.; Kester, M. Nanoparticulate Alternatives for Drug Delivery ACS Nano 2010, 4, 4967-4970
6. Peer, D.; Karp, J. M.; Hong, S.; Farokhzad, O. C.; Margalit, R.; Langer, R. Nanocarriers as an Emerging Platform for Cancer Therapy Nat. Nanotechnol. 2007, 2, 751-760
7. Hrkach, J.; Von Hoff, D.; Ali, M. M.; Andrianova, E.; Auer, J.; Campbell, T.; De Witt, D.; Figa, M.; Figueiredo, M.; Horhota, A. et al. Preclinical Development and Clinical Translation of a Psma-Targeted Docetaxel Nanoparticle with a Differentiated Pharmacological Profile Sci. Transl. Med. 2012, 4, 128-ra39
8. Tan, S. J.; Kiatwuthinon, P.; Roh, Y. H.; Kahn, J. S.; Luo, D. Engineering Nanocarriers for siRNA Delivery Small 2011, 7, 841-856
9. Yoo, J. W.; Irvine, D. J.; Discher, D. E.; Mitragotri, S. Bio-Inspired, Bioengineered and Biomimetic Drug Delivery Carriers Nat. Rev. Drug Discovery 2011, 10, 521-535
10. MacDiarmid, J. A.; Mugridge, N. B.; Weiss, J. C.; Phillips, L.; Burn, A. L.; Paulin, R. P.; Haasdyk, J. E.; Dickson, K. A.; Brahmbhatt, V. N.; Pattison, S. T. et al. Bacterially Derived 400 nm Particles for Encapsulation and Cancer Cell Targeting of Chemotherapeutics Cancer Cell 2007, 11, 431-445
11. MaHam, A.; Tang, Z. W.; Wu, H.; Wang, J.; Lin, Y. H. Protein-Based Nanomedicine Platforms for Drug Delivery Small 2009, 5, 1706-1721
12. Walsh, A. S.; Yin, H. F.; Erben, C. M.; Wood, M. J. A.; Turberfield, A. J. DNA Cage Delivery to Mammalian Cells ACS Nano 2011, 5, 5427-5432
13. Wang, K. L.; You, M. X.; Chen, Y.; Han, D.; Zhu, Z.; Huang, J.; Williams, K.; Yang, C. J.; Tan, W. H. Self-Assembly of a Bifunctional DNA Carrier for Drug Delivery Angew. Chem., Int. Ed. 2011, 50, 6098-6101
14. Lin, X.; Xie, J.; Niu, G.; Zhang, F.; Gao, H. K.; Yang, M.; Quan, Q. M.; Aronova, M. A.; Zhang, G. F.; Lee, S. et al. Chimeric Ferritin Nanocages for Multiple Function Loading and Multimodal Imaging Nano Lett. 2011, 11, 814-819
15. Chang, M.; Yang, C. S.; Huang, D. M. Aptamer-Conjugated DNA Icosahedral Nanoparticles as a Carrier of Doxorubicin for Cancer Therapy ACS Nano 2011, 5, 6156-6163
16. Wu, W.; Hsiao, S. C.; Carrico, Z. M.; Francis, M. B. Genome-Free Viral Capsids as Multivalent Carriers for Taxol Delivery Angew. Chem. Int. Ed. 2009, 48, 9493-9497
17. Steinmetz, N. F.; Ablack, A. L.; Hickey, J. L.; Ablack, J.; Manocha, B.; Mymryk, J. S.; Luyt, L. G.; Lewis, J. D. Intravital Imaging of Human Prostate Cancer Using Viral Nanoparticles Targeted to Gastrin-Releasing Peptide Receptors Small 2011, 7, 1664-1672
18. Hooker, J. M.; Datta, A.; Botta, M.; Raymond, K. N.; Francis, M. B. Magnetic Resonance Contrast Agents from Viral Capsid Shells: A Comparison of Exterior and Interior Cargo Strategies Nano Lett. 2007, 7, 2207-2210
19. Tong, G. J.; Hsiao, S. C.; Carrico, Z. M.; Francis, M. B. Viral Capsid DNA Aptamer Conjugates as Multivalent Cell-Targeting Vehicles J. Am. Chem. Soc. 2009, 131, 11174-11178
20. Ashley, C. E.; Carnes, E. C.; Phillips, G. K.; Durfee, P. N.; Buley, M. D.; Lino, C. A.; Padilla, D. P.; Phillips, B.; Carter, M. B.; Willman, C. L. et al. Cell-Specific Delivery of Diverse Cargos by Bacteriophage Ms2 Virus-like Particles ACS Nano 2011, 5, 5729-5745
21. MacDiarmid, J. A.; Amaro-Mugridge, N. B.; Madrid-Weiss, J.; Sedliarou, I.; Wetzel, S.; Kochar, K.; Brahmbhatt, V. N.; Phillips, L.; Pattison, S. T.; Petti, C. et al. Sequential Treatment of Drug-Resistant Tumors with Targeted Minicells Containing siRNA or a Cytotoxic Drug Nat. Biotechnol. 2009, 27, 643-U97
22. Tang, K.; Zhang, Y.; Zhang, H. F.; Xu, P. W.; Liu, J.; Ma, J. W.; Lv, M.; Li, D. P.; Katirai, F.; Shen, G. X. et al. Delivery of Chemotherapeutic Drugs in Tumour Cell-Derived Microparticles Nat. Commun. 2012, 3, 1282
23. Alvarez-Erviti, L.; Seow, Y. Q.; Yin, H. F.; Betts, C.; Lakhal, S.; Wood, M. J. A. Delivery of siRNA to the Mouse Brain by Systemic Injection of Targeted Exosomes Nat. Biotechnol. 2011, 29, 341-U179
24. Jang, S. C.; Kim, O. Y.; Yoon, C. M.; Choi, D. S.; Roh, T. Y.; Park, J.; Nilsson, J.; Lotvall, J.; Kim, Y. K.; Gho, Y. S. Bioinspired Exosome-Mimetic Nanovesicles for Targeted Delivery of Chemotherapeutics to Malignant Tumors ACS Nano 2013, 7, 7698-7710
25. Lee, E. Y.; Choi, D. S.; Kim, K. P.; Gho, Y. S. Proteomics in Gram-Negative Bacterial Outer Membrane Vesicles Mass Spectrom. Rev. 2008, 27, 535-555
26. Wai, S. N.; Lindmark, B.; Soderblom, T.; Takade, A.; Westermark, M.; Oscarsson, J.; Jass, J.; Richter-Dahlfors, A.; Mizunoe, Y.; Uhlin, B. E. Vesicle-Mediated Export and Assembly of Pore-Forming Oligomers of the Enterobacterial Clya Cytotoxin Cell 2003, 115, 25-35
27. Kuehn, M. J.; Kesty, N. C. Bacterial Outer Membrane Vesicles and the Host-Pathogen Interaction Gene Dev. 2005, 19, 2645-2655
28. Kim, J. Y.; Doody, A. M.; Chen, D. J.; Cremona, G. H.; Shuler, M. L.; Putnam, D.; DeLisa, M. P. Engineered Bacterial Outer Membrane Vesicles with Enhanced Functionality J. Mol. Biol. 2008, 380, 51-66
29. Chen, D. J.; Osterrieder, N.; Metzger, S. M.; Buckles, E.; Doody, A. M.; DeLisa, M. P.; Putnam, D. Delivery of Foreign Antigens by Engineered Outer Membrane Vesicle Vaccines Proc. Natl. Acad. Sci. U.S.A. 2010, 107, 3099-3104
30. Baselga, J.; Swain, S. M. Novel Anticancer Targets: Revisiting Erbb2 and Discovering Erbb3 Nat. Rev. Cancer 2009, 9, 463-475
31. Hynes, N. E.; Lane, H. A. Erbb Receptors and Cancer: The Complexity of Targeted Inhibitors Nat. Rev. Cancer 2005, 5, 341-354
32. Yarden, Y.; Sliwkowski, M. X. Untangling the Erbb Signalling Network Nat. Rev. Mol. Cell Biol. 2001, 2, 127-137
33. Olayioye, M. A.; Neve, R. M.; Lane, H. A.; Hynes, N. E. The Erbb Signaling Network: Receptor Heterodimerization in Development and Cancer Embo J. 2000, 19, 3159-3167
34. Orlova, A.; Magnusson, M.; Eriksson, T. L. J.; Nilsson, M.; Larsson, B.; Hoiden-Guthenherg, I.; Widstrom, C.; Carlsson, J.; Tolmachev, V.; Stahl, S. et al. Tumor Imaging Using a Picomolar Affinity Her2 Binding Affibody Molecule Cancer Res. 2006, 66, 4339-4348
35. Hajjar, A. M.; Ernst, R. K.; Tsai, J. H.; Wilson, C. B.; Miller, S. I. Human Toll-Like Receptor 4 Recognizes Host-Specific LPS Modifications Nat. Immunol. 2002, 3, 354-359
36. Kim, S. H.; Kim, K. S.; Lee, S. R.; Kim, E.; Kim, M. S.; Lee, E. Y.; Gho, Y. S.; Kim, J. W.; Bishop, R. E.; Chang, K. T. Structural Modifications of Outer Membrane Vesicles to Refine Them as Vaccine Delivery Vehicles Bba-Biomembranes 2009, 1788, 2150-2159
37. Somerville, J. E.; Cassiano, L.; Darveau, R. P. Escherichia Coli MsbB Gene as a Virulence Factor and a Therapeutic Target Infect. Immun. 1999, 67, 6583-6590
38. Jackson, J. R.; Patrick, D. R.; Dar, M. M.; Huang, P. S. Targeted Anti-Mitotic Therapies: Can We Improve on Tubulin Agents? Nat. Rev. Cancer 2007, 7, 107-117
39. Judge, A. D.; Robbins, M.; Tavakoli, I.; Levi, J.; Hu, L.; Fronda, A.; Ambegia, E.; McClintock, K.; MacLachlan, I. Confirming the RNAi-Mediated Mechanism of Action of siRNA-Based Cancer Therapeutics in Mice J. Clin. Invest. 2009, 119, 661-673
40. Knight, S. D.; Parrish, C. A. Recent Progress in the Identification and Clinical Evaluation of Inhibitors of the Mitotic Kinesin KSP Curr. Top. Med. Chem. 2008, 8, 888-904
41. Tao, W. K.; South, V. J.; Zhang, Y.; Davide, J. P.; Farrell, L.; Kohl, N. E.; Sepp-Lorenzino, L.; Lobell, R. B. Induction of Apoptosis by an Inhibitor of the Mitotic Kinesin KSP Requires Both Activation of the Spindle Assembly Checkpoint and Mitotic Slippage Cancer Cell 2005, 8, 49-59
42. Amano, A.; Takeuchi, H.; Furuta, N. Outer Membrane Vesicles Function as Offensive Weapons in Host-Parasite Interactions Microbes Infect. 2010, 12, 791-798
43. Furuta, N.; Tsuda, K.; Omori, H.; Yoshimori, T.; Yoshimura, F.; Amano, A. Porphyromonas Gingivalis Outer Membrane Vesicles Enter Human Epithelial Cells via an Endocytic Pathway and Are Sorted to Lysosomal Compartments Infect. Immun. 2009, 77, 4187-4196
44. Kim, S.; Kim, D.; Jung, H. H.; Lee, I. H.; Kim, J. I.; Suh, J. Y.; Jon, S. Bio-Inspired Design and Potential Biomedical Applications of a Novel Class of High-Affinity Peptides Angew. Chem., Int. Ed. 2012, 51, 1890-1894
45. Bagalkot, V.; Farokhzad, O. C.; Langer, R.; Jon, S. An Aptamer-Doxorubicin Physical Conjugate as a Novel Targeted Drug-Delivery Platform Angew. Chem., Int. Ed. 2006, 45, 8149-8152
46. Yu, M. K.; Jeong, Y. Y.; Park, J.; Park, S.; Kim, J. W.; Min, J. J.; Kim, K.; Jon, S. Drug-Loaded Superparamagnetic Iron Oxide Nanoparticles for Combined Cancer Imaging and Therapy in Vivo Angew. Chem., Int. Ed. 2008, 47, 5362-5365
47. Letsch, M.; Schally, A. V.; Busto, R.; Bajo, A. M.; Varga, J. L. Growth Hormone-Releasing Hormone (Ghrh) Antagonists Inhibit the Proliferation of Androgen-Dependent and-Independent Prostate Cancers Proc. Natl. Acad. Sci. U.S.A. 2003, 100, 1250-1255
48. Yu, M. K.; Kim, D.; Lee, I. H.; So, J. S.; Jeong, Y. Y.; Jon, S. Image-Guided Prostate Cancer Therapy Using Aptamer-Functionalized Thermally Cross-Linked Superparamagnetic Iron Oxide Nanoparticles Small 2011, 7, 2241-2249
49. Takashiba, S.; Van Dyke, T. E.; Amar, S.; Murayama, Y.; Soskolne, A. W.; Shapira, L. Differentiation of Monocytes to Macrophages Primes Cells for Lipopolysaccharide Stimulation via Accumulation of Cytoplasmic Nuclear Factor Kappa B Infect. Immun. 1999, 67, 5573-5578